Concepedia

Elaine M. Pinheiro

EM

Statistics

Publications

16

Citations

2.6K

H-Index

15

Active since

2003

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Massachusetts Institute of Technology

Johns Hopkins University

Johns Hopkins Medicine

Dana-Farber Cancer Institute

Elaine M. Pinheiro is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in life sciences, immunology, and oncology.

Publications per year

2003–2024

16

Publications

16

Discovery of a Novel ERK Inhibitor with Activity in Models of Acquired Resistance to BRAF and MEK Inhibitors

Erick J. Morris, Sharda Jha, Clifford R. Restaino et al. · Cancer Discovery · 2013 · 685 citations · Full text

, , +17

Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in <i>BRAF</i> <sup> <i>V600E</i> </sup> melanoma

Siwen Hu‐Lieskovan, Stephen Mok, Blanca Homet Moreno et al. · Science Translational Medicine · 2015 · 568 citations · Full text

, , +14

Ena/VASP Is Required for Neuritogenesis in the Developing Cortex

Adam V. Kwiatkowski, Douglas A. Rubinson, Erik W. Dent et al. · Neuron · 2007 · 228 citations · Full text

, , +12

Dinaciclib induces immunogenic cell death and enhances anti-PD1–mediated tumor suppression

Dewan Md Sakib Hossain, Sarah Javaid, Mingmei Cai et al. · Journal of Clinical Investigation · 2018 · 218 citations · Full text

, , +17

PVF1, a PDGF/VEGF homolog, is sufficient to guide border cells and interacts genetically with Taiman

Jocelyn A. McDonald, Elaine M. Pinheiro, Denise J. Montell · Development · 2003 · 153 citations

, , +14

1–5 of 16